Author: Perfusion.com

Because the Revolution centrifugal pump, which was recently designed and distributed, produced results comparable with those obtained with the BioPump, it should be considered as safe as the Bio-Pump to perform clinical CPB.

Argatroban can effectively reduce thrombin generation and prolong activated clotting in vitro.

Isoflurane, a volatile anesthetic, administered during ischemia/reoxygenation, aggravated functional impairment in heart muscle cells.

This study evaluates the thrombelastograph as a new assay of blood clotting times; it is activated by the addition of tissue clotting factor and kaolin and used to monitor heparin anticoagulation during cardiopulmonary bypass.

A more refined analysis of the human genome shows that people have fewer genes than originally believed, according to researchers working on the Human Genome Project, a publicly funded collaboration of scientists from 20 institutions in the United States, Europe and Asia.

A minimally invasive approach to curing the most common heart rhythm abnormality, atrial fibrillation, takes half the time of the traditional surgical procedure but is equally effective, according to research at Washington University School of Medicine in St. Louis.

Liquid bioartificial tissue containing embryonic stem cells constitutes a powerful new approach to restoring injured heart muscle without distorting its geometry and structure.

Although the observed incidence of adverse events is likely to be an underestimate, nevertheless both non-fatal and fatal serious adverse events in albumin recipients appear to be rare.

There is insufficient evidence to recommend the routine use of cell salvage in elective abdominal aortic aneurysm and aorto-femoral bypass surgeries.

Postoperative AF is common after surgical correction of MR in patients with no prior history of AF and is associated with increased subsequent morbidity.

These results suggest that argatroban may be more efficacious than heparin for anticoagulation in ECMO.